Finding a Gap: Achieving Good Response Rates in Difficult Tumor Types

2:00 pm - Thursday 10th September 2026

  • How do established payloads compare in their ability to drive meaningful clinical responses?
  • Have historically pursued targets lacked sufficient expression or accessibility to enable effective tumor penetration?
  • What role can mechanisms play in increasing efficacy?

Speakers:

CBO
Aarvik Therapeutics
Director Business Development & Transactions
AbCellera
Co-Founder & Chief Executive Officer
Antelope Therapeutics
cso
Iksuda